CHRISTY HILL: Open Payments
NPI 1275044604 · NEW LEXINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 57 payments from 15 companies in 2025. Trend: 2023 $1,184 · 2024 $1,181 · 2025 $946
Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $213 |
| AstraZeneca Pharmaceuticals LP | 8 | $205 |
| Corcept Therapeutics | 11 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| Novo Nordisk Inc | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| PFIZER INC. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Verona Pharma, Inc. | 1 | $20 |
Products named: Korlym, AIRSUPRA, VRAYLAR, CAPLYTA, QULIPTA, FARXIGA, REXULTI, NURTEC ODT.
Industry payments across OH — which companies pay providers there.
